Seizures
Welcome,         Profile    Billing    Logout  
 21 Companies   32 Products   32 Products   31 Mechanisms of Action   0 Trials   632 News 


123456789101112»
  • ||||||||||  topiramate / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date, Surgery:  Preventing Brain Injury in Infants With Congenital Heart Disease (clinicaltrials.gov) -  Feb 8, 2019   
    P1,  N=24, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Jul 2017 | Trial primary completion date: Jan 2019 --> Jul 2017
  • ||||||||||  Trial completion, Enrollment change:  Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training (clinicaltrials.gov) -  Feb 5, 2019   
    P=N/A,  N=36, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Jul 2017 | Trial primary completion date: Jan 2019 --> Jul 2017 Recruiting --> Completed | N=24 --> 36
  • ||||||||||  lacosamide / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Lacosamide in Preventing Seizures in Participants With Malignant Glioma (clinicaltrials.gov) -  Dec 20, 2018   
    P=N/A,  N=37, Terminated, 
    Recruiting --> Completed | N=24 --> 36 N=302 --> 37 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2018 --> Jun 2017
  • ||||||||||  Trial completion date:  Exercise Education for Adults With Seizure Disorders (clinicaltrials.gov) -  Dec 11, 2018   
    P1,  N=30, Completed, 
    N=302 --> 37 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2018 --> Jun 2017 Trial completion date: Jan 2017 --> Dec 2018
  • ||||||||||  topiramate / Generic mfg.
    Trial completion date, Trial primary completion date, Surgery:  Preventing Brain Injury in Infants With Congenital Heart Disease (clinicaltrials.gov) -  Oct 18, 2018   
    P1,  N=24, Active, not recruiting, 
    Trial primary completion date: Oct 2015 --> Oct 2017 Trial completion date: Aug 2018 --> Jan 2019 | Trial primary completion date: Aug 2018 --> Jan 2019
  • ||||||||||  Trial completion:  Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression (clinicaltrials.gov) -  Aug 7, 2018   
    P3,  N=30, Completed, 
    Recruiting --> Completed | Trial completion date: Jun 2017 --> Feb 2018 | Trial primary completion date: Jun 2017 --> Feb 2018 Active, not recruiting --> Completed
  • ||||||||||  Potiga (retigabine) / Bausch Health, GSK
    Trial termination:  Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097 (clinicaltrials.gov) -  Aug 1, 2018   
    P3,  N=376, Terminated, 
    Active, not recruiting --> Completed Active, not recruiting --> Terminated; No longer any benefit in collecting data since retigabine has been withdrawn from market.
  • ||||||||||  Trial completion:  Berlin Magnetic Seizure Therapy Depression Trial 01 (clinicaltrials.gov) -  Jul 13, 2018   
    P3,  N=32, Completed, 
    Active, not recruiting --> Terminated; No longer any benefit in collecting data since retigabine has been withdrawn from market. Recruiting --> Completed
  • ||||||||||  Phase classification:  People Presenting With Neurocysticercosis in North America (clinicaltrials.gov) -  Apr 6, 2018   
    P,  N=11, Terminated, 
    Phase classification: P2 --> P=N/A Phase classification: P=N/A --> P
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Clinical-genetic Investigations in Children With Early Infantile Epilepsies (clinicaltrials.gov) -  Feb 12, 2018   
    P=N/A,  N=75, Completed, 
    N=700 --> 104 Recruiting --> Completed | N=50 --> 75 | Trial primary completion date: Jun 2015 --> Dec 2017 | Trial completion date: Jun 2015 --> Dec 2017
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date, HEOR:  STEP: Enhanced Physical Activity in Children and Youth With Epilepsy (clinicaltrials.gov) -  Feb 5, 2018   
    P=N/A,  N=122, Active, not recruiting, 
    Recruiting --> Completed | N=50 --> 75 | Trial primary completion date: Jun 2015 --> Dec 2017 | Trial completion date: Jun 2015 --> Dec 2017 Recruiting --> Active, not recruiting | N=200 --> 122 | Trial primary completion date: Mar 2017 --> Mar 2018
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder (clinicaltrials.gov) -  Feb 5, 2018   
    P3,  N=53, Completed, 
    Recruiting --> Active, not recruiting | N=200 --> 122 | Trial primary completion date: Mar 2017 --> Mar 2018 Active, not recruiting --> Completed | Trial primary completion date: Jan 2018 --> Jun 2017 | Trial completion date: Jan 2018 --> Jun 2017
  • ||||||||||  Trial completion:  Modified Atkins Diet Plus KetoCal for Adult Epilepsy (clinicaltrials.gov) -  Jan 24, 2018   
    P=N/A,  N=80, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Oct 2017 --> Oct 2015 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures (clinicaltrials.gov) -  Dec 20, 2017   
    P=N/A,  N=29, Completed, 
    N=86 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed | N=80 --> 29 | Trial primary completion date: Nov 2016 --> Jan 2016
  • ||||||||||  phenytoin / Generic mfg., levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
    New trial:  Antiepileptic Drugs and Vascular Risk Markers (clinicaltrials.gov) -  Dec 19, 2017   
    P=N/A,  N=52, Terminated, 
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression. (clinicaltrials.gov) -  Nov 20, 2017   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | N=80 --> 29 | Trial primary completion date: Nov 2016 --> Jan 2016 N=200 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2018 --> Dec 2016
  • ||||||||||  levetiracetam / Generic mfg.
    Trial completion, Enrollment change:  Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children (clinicaltrials.gov) -  Nov 14, 2017   
    P1,  N=108, Completed, 
    N=200 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2018 --> Dec 2016 Active, not recruiting --> Completed | N=144 --> 108
  • ||||||||||  sertraline / Generic mfg.
    Trial completion, HEOR:  Depression and Health Outcomes in Refractory Epilepsy (clinicaltrials.gov) -  Nov 7, 2017   
    P3,  N=140, Completed, 
    Recruiting --> Active, not recruiting Terminated --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors (clinicaltrials.gov) -  Nov 7, 2017   
    P=N/A,  N=97, Completed, 
    Terminated --> Completed Recruiting --> Completed | N=560 --> 97 | Trial primary completion date: Dec 2013 --> Sep 2014
  • ||||||||||  levetiracetam / Generic mfg.
    Enrollment change, Trial initiation date, Trial primary completion date:  SPLASH - Pilot: Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study (clinicaltrials.gov) -  Nov 1, 2017   
    P4,  N=0, Withdrawn, 
    Recruiting --> Completed | N=560 --> 97 | Trial primary completion date: Dec 2013 --> Sep 2014 N=36 --> 0 | Initiation date: Jan 2014 --> May 2013 | Trial primary completion date: Sep 2014 --> May 2013
  • ||||||||||  Phase classification, Enrollment change, Trial termination, Surgery:  Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy (clinicaltrials.gov) -  Sep 25, 2017   
    P=N/A,  N=3, Terminated, 
    Recruiting --> Completed Phase classification: P4 --> P=N/A | N=120 --> 3 | Not yet recruiting --> Terminated; The study oversight committees unanimously decided to stop the study early on 26/07/2017 due to poor recruitment.
  • ||||||||||  Trial completion:  Copeptin in Childhood Epilepsy (clinicaltrials.gov) -  Sep 19, 2017   
    P=N/A,  N=340, Completed, 
    Phase classification: P4 --> P=N/A | N=120 --> 3 | Not yet recruiting --> Terminated; The study oversight committees unanimously decided to stop the study early on 26/07/2017 due to poor recruitment. Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date, Intubation:  Early Versus Late Intubation Trial in Physician Manned Emergency Medical Services (clinicaltrials.gov) -  Sep 19, 2017   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed N=500 --> 0 | Initiation date: Sep 2013 --> Jan 2015 | Suspended --> Withdrawn | Trial primary completion date: Dec 2015 --> Mar 2017
  • ||||||||||  carbamazepine / Generic mfg.
    Enrollment change, Adverse drug reaction:  Pathogenesis of Adverse Drug Reactions (clinicaltrials.gov) -  Aug 14, 2017   
    P=N/A,  N=274, Completed, 
    Trial primary completion date: Dec 2016 --> Apr 2017 N=98 --> 274
  • ||||||||||  Trial completion:  MRI in Autosomal Dominant Partial Epilepsy With Auditory Features (clinicaltrials.gov) -  Jun 30, 2017   
    P=N/A,  N=72, Completed, 
    Recruiting --> Active, not recruiting | N=80 --> 55 Recruiting --> Completed